Recombinant Human Leukemia inhibitory factor/LIF Protein
Recombinant Human Leukemia inhibitory factor/LIF Protein (RP01697-GRP)
Products
Description
Recombinant Human Leukemia inhibitory factor/LIF Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser23-Phe202) of human Leukemia inhibitory factor/LIF (Accession #NP_002300.1) fused with no additional amino acid.
Specifications
| Manufacturer | Abclonal Biotechnology |
|---|---|
| Manufacturer Cat# | RP01697 |
| Bio-Activity | Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is 0.14-0.54 ng/mL, corresponding to a specific activity of 1.85×106-7.14×106 units/mg. |
| Alternate Names | CDF; DIA; HILDA; MLPLI;LIF |
| Reactivity | Human |
| Gene ID | 3976 |
| Swiss Prot | P15018 |